Companies: 10,795·Total market cap: $144.5T
Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals, Inc.

ADILNASDAQHealthcare● Active
$2.21
+$0.00(+0.00%)
Market Cap$2120813
P/E Ratio—
52W High$19
52W Low$1.31
Overview

Adial Pharmaceuticals, Inc.（ADIL）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

adil · 股价预测 · 3 位分析师（近3月）· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 3 位华尔街分析师

SellBuy

Buy

3 位分析师

共识

评级分布

Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
合计: 3 · 买入占比: 100.0%

12 个月目标价

High

$8.00

Consensus

$8.00

+262.0% upside

Low

$8.00

Median: $8 · Last Close: $2.21

Adial Pharmaceuticals, Inc.（ADIL）的分析师共识为 Buy，基于过去 3 个月内 3 位华尔街分析师的评级。ADIL 的 12 个月平均目标价为 $8.00，相对当前价 $2.21 代表 +262.0% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$2.32↑ 5.00%

1-day model range: $2.29–$2.35. Peak: $2.35 (+5.00%).

长期股价预测

⚠️ 在满 252 个交易日历史（IPO/上市时间较短）前不展示长期预测；短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

36%7%57%
5Buy
1Neutral
8Sell
RSI (14)64.4Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · ADIL · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$2.30SELL
MA 10$2.35SELL
MA 20$2.04BUY
MA 50$1.78BUY
MA 100$2.51SELL
MA 200$5.33SELL
Current $ADIL · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$2.28SELL
EMA 10$2.26SELL
EMA 20$2.12BUY
EMA 50$2.09BUY
EMA 100$2.91SELL
EMA 200$5.33SELL
Current $ADIL · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Maxim Group2025-09-30
Upgrade ↑
Hold→Buy
Brookline Capital2023-07-11
Maintains
Buy→Buy
Maxim Group2022-08-17
Downgrade ↓
Buy→Hold
Brookline Capital2021-10-13
Maintains
Buy→Buy
Litchfield Hills2021-06-29
Maintains
Buy→Buy

Wall Street analysts have recently issued updated ratings on Adial Pharmaceuticals, Inc. (ADIL) stock. Of the recent 5 rating actions, 1 were upgrades and 1 were downgrades. 3 analysts currently cover ADIL.

分析师推荐趋势

Buy ratings1 → 1
Hold ratings0 → 0
Sell ratings0 → 0

ADIL analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$46M

↓ 2.1% YoY

Revenue Next Year

$4M

↓ 90.4% YoY

EPS This Year

$-5.26

EPS Next Year

$-2.49

↓ 52.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ADIL EPS of $-5.26 for the current fiscal year, based on estimates from 1 analysts. The ADIL revenue forecast is $46M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

ADIL 股价预测由两类独立数据源支撑：来自 3 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ADIL 的共识目标价为 $8.00（+262.0% 上行空间），分析师共识为 Buy。

ADIL 的短期预测（明日）为 $2.32（+5.00%）。

Adial Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 ADIL。ADIL 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

相关页面

盈利营收市盈率财务报表市值内幕交易股息价格历史

常见问题

ADIL 预测 · 8 个问题

根据 3 位华尔街分析师，ADIL 的 12 个月平均目标价为 $8.00，最高 $8.00、最低 $8.00。若有图表，中位目标价可在上方查看。相对当前价 $2.21，隐含约 +262.0% 的上行空间。

ADIL 目标价ADIL 分析师目标价ADIL 12个月目标价目标价 ADIL

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.